| HR | 95% CI | p value |
---|---|---|---|
Univariate analysis | |||
Age (continuous) | 1.017 | 0.973–1.063 | 0.456 |
ECOG (continuous) | 1.641 | 1.398–1.927 | < 0.001 |
Gender (reference: female) | 1.483 | 1.156–1.903 | 0.002 |
Systemic treatment (reference: systemic treatment) | 0.887 | 0.676–1.165 | 0.390 |
Primary cancer (reference: genitourinary) | 1.038 | 0.810–1.329 | 0.770 |
Primary cancer (reference: breast) | 1.914 | 1.423–2.576 | < 0.001 |
Mizumoto score (continuous) | 1.164 | 1.080–1.255 | < 0.001 |
SINS (continuous) | 1.076 | 1.029–1.126 | 0.001 |
Multivariate analysis | |||
ECOG (continuous) | 1.411 | 1.174–1.695 | < 0.001 |
Gender (reference: female) | 0.731 | 0.473–1.130 | 0.159 |
Primary cancer (reference: breast) | 1.578 | 0.934–2.667 | 0.088 |
Mizumoto score (continuous) | 1.127 | 1.040–1.222 | 0.004 |
SINS (continuous) | 1.100 | 1.047–1.155 | < 0.001 |